We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Zymeworks
ZYME
$1.6B
| $47.8M | 0.06% |
1,908,039
+85,991
| +5% | +$2.03M |
|
327
Insulet
PODD
$11.8B
| $47.2M | 0.05% |
224,873
-33,902
| -13% | -$8.52M |
|
328
Cytokinetics
CYTK
$10.4B
| $47.1M | 0.05% |
714,344
-113,519
| -14% | -$7.21M |
|
329
Casella Waste Systems
CWST
$5.85B
| $47M | 0.05% |
593,009
+91,913
| +18% | +$8.81M |
|
330
Cardinal Health
CAH
$55.2B
| $46.8M | 0.05% |
222,046
-42,361
| -16% | -$9.12M |
|
331
Carnival Corporation Ltd
CCL
$39.4B
| $46.8M | 0.05% |
1,806,895
+1,334,326
| +282% | +$38.9M |
|
332
Eversource Energy
ES
$27.1B
| $46.7M | 0.05% |
673,545
+14,688
| +2% | +$1.04M |
|
333
Martin Marietta Materials
MLM
$32.6B
| $46.4M | 0.05% |
78,894
+55,233
| +233% | +$35.2M |
|
334
Varonis Systems
VRNS
$4.73B
| $46.3M | 0.05% |
2,156,578
-575,978
| -21% | -$15.6M |
|
335
Comcast
CMCSA
$87.2B
| $46.2M | 0.05% |
1,608,513
-1,010,413
| -39% | -$30.2M |
|
336
Cigna
CI
$74.5B
| $46.1M | 0.05% |
172,964
+40,122
| +30% | +$11.1M |
|
337
Edison International
EIX
$27.5B
| $45.8M | 0.05% |
625,546
+89,247
| +17% | +$6.02M |
|
338
Principal Financial Group
PFG
$24.6B
| $45.7M | 0.05% |
507,575
+70,358
| +16% | +$6.43M |
|
339
Hewlett Packard
HPE
$66.5B
| $45.7M | 0.05% |
1,917,760
+751,283
| +64% | +$16.6M |
|
340
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.59B
| $45.6M | 0.05% |
1,077,221
| – | – |
|
341
iShares MBS ETF
MBB
$38.8B
| $45.4M | 0.05% |
477,622
-455,365
| -49% | -$43.5M |
|
|
XYZ
342
Block Inc
XYZ
$48.9B
| $45.3M | 0.05% |
752,961
+14,555
| +2% | +$885K |
|
343
Pentair
PNR
$10.7B
| $45.3M | 0.05% |
520,152
+65,460
| +14% | +$6.41M |
|
344
Quest Diagnostics
DGX
$25.6B
| $45.3M | 0.05% |
230,934
+5,640
| +3% | +$1.1M |
|
|
FITB
345
Fifth Third Bancorp
FITB
$51.6B
| $44.9M | 0.05% |
965,800
+151,330
| +19% | +$7.46M |
|
346
Marriott International
MAR
$91.5B
| $44.7M | 0.05% |
136,569
-19,028
| -12% | -$6.26M |
|
347
ON Semiconductor
ON
$31.3B
| $44.5M | 0.05% |
718,599
-559,994
| -44% | -$35.1M |
|
348
Corteva
CTVA
$50.9B
| $44.5M | 0.05% |
531,478
-450,764
| -46% | -$34M |
|
349
Avery Dennison
AVY
$13.2B
| $44.5M | 0.05% |
257,510
-24,471
| -9% | -$4.49M |
|
350
Repligen
RGEN
$8.3B
| $44.4M | 0.05% |
377,009
+53,188
| +16% | +$7.43M |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.